CLSI H30
Procedure for the Determination of Fibrinogen in Plasma, 2nd Edition
This document provides general guidelines for performing the fibrinogen assay in the clinical laboratory. It also includes reporting of results and in vivo and in vitro conditions that may alter results. (See related publication H21-A3 in this section.)
This document is available in electronic format only.
Member price:
List Price:Details
Chairholder: Charles F. Arkin, MD
Date of Publication: November 1, 2001
Order Code PDF: CLSI H30A2E
ISBN Number: 1-56238-439-2
Order Code Print: print not available
Edition: Second
Pages: 16
CLSI H30 Additional Details
If interested in ordering larger quantities of this document in print, please contact us here.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.
This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid as of September 2016. Because of its value to the laboratory community, it is being retained in CLSI’s library.